The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York What's the Difference Between FDA Emergency Use Authorization and FDA Approval? UNC Health Talk Advancing patient care: A look at new medicines approved in 2025 PhRMA FDA's accelerated approval process: What your audience needs to know